Resource Library

The MDS Foundation Resource Center Library contains all of the educational materials presented on this site. You may search for a specific topic or select content based on the media format in which it is presented. Just click on the program format you wish to view.

Effective Therapeutic Decision Making in MDS: Improving Patient Outcomes and Quality of Life

• Click here to view the MDS Foundation symposium held at the ASH Conference on December 4, 2009

Understanding MDS - A Primer for Practicing Clinicians

• Segment 1: The Past & Present in MDS
• Segment 2: Clinical Presentation, Diagnosis & Pathology
• Segment 3: Inaffective Hematopoiesis: Considerations in Diagnosis and Treatment
• Segment 4: Anemia in MDS: Survival, QoL, and Treatment Options
• Segment 5: Treatment Strategies in MDS: Evolution in Current and Novel Therapies in MDS (Coming Soon)
• Segment 6: Understanding the Minimal Diagnostic Criteria for MDS (Coming Soon)

• Environmental and Molecular Epidemiology of MDS
  David T. Bowen
• Risk Factors for Myelodysplastic Syndrome and Leukemia after Breast Cancer: Results of a French Multicenter Case-Control Study
  Pierre Fenaux, MD
• Historical Perspectives on Classification Issues in MDS
  John M. Bennett, MD
• Prospective Validation of the WHO Classification of Primary MDS
  Ulrich Germing, MD
• Thalidomide Analogue CC5013 (Revlimid) Selectively Inhibits in Vitro Growth of the Malignant Clone in MDS Patients with 5q Deletion
  Martin Jädersten, MD
• Diagnostic Value of Array-based CGH in MDS, Lukasz Gondek
• Incidence of Cytogenetic Response in MDS/AML Patients with Complex Karyotype Receiving Low-dose 5-Aza-2 deoxycytidine (Decitabine) Treatment
  Michael Lübbert, MD, PhD
• Reversing Gene Silencing in Myelodysplastic Syndromes
  Stephen D. Nimer, MD
• Studies in MDS
  H. Phillip Koeffler, MD
• Cytogenetic Profile in 2124 Patients with MDS Correlations with Morphology
  Clinical Course and Prognosis, Detlef Haase, MD
• New Treatment Strategies in MDS
  Alan F. List, MD
• Global Management of MDS
  Eva Hellström-Lindberg, MD, PhD
• Juvenile Myelomonocytic Leukemia (JMML): From Clinical Examination to Molecular Genetics
  Charlotte M. Niemeyer, MD
• Treatment and Biology of Iron Overload in MDS: New Oral Iron Chelating Agents
  Peter L. Greenberg, MD
• Management of the Anemia of MDS
  Eva Hellström-Lindberg, MD, PhD
• Hematopoietic Stem Cell Strategies in Patients with MDS and Secondary Acute Myeloid Leukemia: The Role of Reduced Intensity Conditioning Regimens
  Theo J. M. de Witte, MD, PhD
• Hemopoietic Cell Transplantation for the Treatment of MDS
  H. Joachim Deeg, MD
• The Use of 5-Azacytidine in MDS: An Evolving Therapy
  Pierre Fenaux, MD
• The Role of Chemotherapy in the Treatment of MDS
  Arnold Ganser, MD
• Morphology Summary
  John M. Bennett, MD
• Morphology Summary
  Ghulam J. Mufti, MD
• Meeting Summary
  Masao Tomonaga, MD